In vitro–in vivo extrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations

@article{Pelkonen2007InVV,
  title={In vitro–in vivo extrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations},
  author={Olavi Pelkonen and M Turpeinen},
  journal={Xenobiotica},
  year={2007},
  volume={37},
  pages={1066 - 1089}
}
Although the measurement of metabolite formation or substrate depletion in in vitro systems, from recombinant enzymes to tissue slices, is a relatively routine task, there are a number of more or less unresolved issues in the extrapolation of the enzymatic intrinsic clearance into hepatic metabolic clearance. Nominal concentrations of the drug added to the incubation system are not necessarily the concentration the transporter or the metabolizing enzyme sees. In addition, peculiarities of… Expand
In vitro–in vivo extrapolation of metabolic clearance using human liver microsomes: factors showing variability and their normalization
TLDR
The results suggest the normalization of variability might be useful for predicting the in vivo CLint, u values from various microsomal batches. Expand
In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods.
TLDR
A significant improvement in the mechanism-based prediction of metabolic CL for these 25 highly bound drugs from in vitro data determined with microsomes is demonstrated, which should facilitate the application of physiologically based pharmacokinetic (PBPK) models in drug discovery and development. Expand
Consideration of the unbound drug concentration in enzyme kinetics.
TLDR
The underlying mechanisms determining the free drug concentration in vitro are described and how these factors can be accounted for in drug metabolism studies are illustrated with case studies from the literature. Expand
Consideration of the Unbound Drug Concentration in Enzyme Kinetics.
TLDR
The underlying mechanisms determining the free drug concentration in vitro are described and how these factors can be accounted for in drug metabolism studies are illustrated with case studies from the literature. Expand
Comparative assessment of In Vitro-In Vivo extrapolation methods used for predicting hepatic metabolic clearance of drugs.
TLDR
The Poulin et al. method is robust and showed the greatest accuracy as compared with the other IVIVE methods in the majority of prediction scenarios studied here, which should facilitate the use of IVIVE correlation methods in physiologically based pharmacokinetics (PBPK) model. Expand
Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment.
TLDR
The use of QIVIVE methods in a high-throughput environment and the promise they hold in shaping chemical testing priorities and, potentially, high-Throughput risk assessment strategies are described. Expand
Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results
TLDR
This review describes the various elements of QIVIVE and highlights key aspects of the process, with an emphasis on extrapolation of in vitro metabolism data to predict in vivo clearance as the key element. Expand
Biotransformation in vitro: An essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity data.
TLDR
The current status of in vitro metabolism studies for QIVIVE extrapolation, serving today's hazard and risk assessment needs is discussed and the need for more streamlined and explicitly described integrated approaches to reflect the physiology and the related dynamic and kinetic processes of the human body is highlighted. Expand
Relevance of In Vitro Metabolism Models to PET Radiotracer Development: Prediction of In Vivo Clearance in Rats from Microsomal Stability Data
TLDR
The result indicates that the prediction of radiotracer clearance is possible despite concentration differences of more than three orders of magnitude between in vitro and in vivo conditions, and in vitro metabolism models represent a valuable tool for PET radiotsracer development. Expand
In silico modelling of transporter-mediated xenobiotic flux through cells
Drug transporters are increasingly recognised as important drivers in the pharmaco- and toxico-kinetic characteristics of therapeutic agents. Preclinical assays are used to determine the effects ofExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 114 REFERENCES
Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data.
TLDR
Scaling of in vivo metabolic clearance from in vitro data obtained using human liver microsomes or hepatocytes is described in this review, based on the large number of literature data, and it appears to be possible to predict in vivo drug metabolic clearanceFrom in vitro metabolic data. Expand
Comparison of the Use of Liver Models for Predicting Drug Clearance Using in Vitro Kinetic Data from Hepatic Microsomes and Isolated Hepatocytes
TLDR
Considering the statistics of the predictions for three liver models, the use of parallel tube model is recommended for the evaluation of in vitro CLint values both from microsomes and hepatocytes, as there are minimal differences between the models. Expand
A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES
TLDR
The direct use of this model using only in vitro human data to predict the metabolic component of CLh is attractive, as it does not require extra information from preclinical studies in animals. Expand
Use of Hepatocytes to Assess the Contribution of Hepatic Uptake to Clearance in Vivo
TLDR
This work has described a simple method, amenable for use within a drug discovery setting, for predicting the in vivo clearance of drugs with significant hepatic uptake, and accurate prediction of human CLint ub in vivo for the marketed drug transporter substrates montelukast, bosentan, atorvastatin, and pravastatin. Expand
Investigation of the utility of published in vitro intrinsic clearance data for prediction of in vivo clearance.
TLDR
The literature paucity and variability described here demonstrate the importance of generating experimentally consistent de novo CL,i data for the purpose of method validation or in vitro-in vivo scaling. Expand
Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.
  • R. Obach
  • Chemistry, Medicine
  • Drug metabolism and disposition: the biological fate of chemicals
  • 1999
TLDR
In the projection of human clearance values, basic and neutral compounds were well predicted when all binding considerations (blood and microsome) were disregarded, however, including both binding considerations also yielded reasonable predictions. Expand
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.
TLDR
The findings indicate the importance of considering differences between study populations when forecasting in vivo pharmacokinetic behaviour and recommend that the estimates (and their variances) from the current meta-analysis be used when predicting in vivo kinetic parameters from in vitro data. Expand
Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method.
TLDR
Data suggested that the calibration of inherent interindividual variation of metabolic activities among different cryopreserved preparations of human hepatocytes to obtain the empirical scaling factor was an essential step for more reliable and quantitative prediction of in vivo metabolic activity in humans. Expand
Correlation between in vivo and in vitro hepatic uptake of metabolic inhibitors of cytochrome P-450 in rats.
TLDR
It may be possible to predict the drug concentrations in human liver from K(Bf) values estimated with isolated human hepatocytes and concentrations in the blood in a similar manner as in rats. Expand
The prediction of human clearance from hepatic microsomal metabolism data.
  • R. Obach
  • Medicine
  • Current opinion in drug discovery & development
  • 2001
TLDR
The theoretical and practical aspects of predicting clearance from human liver microsomal intrinsic clearance data are described, a summary of advantages and shortcomings of this in vitro system, a synopsis of recent applications, and a discussion of potential future directions for this field are described. Expand
...
1
2
3
4
5
...